We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
106 hedge funds and large institutions have $33.5M invested in Accelerate Diagnostics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
1% less funds holding
Funds holding: 107 → 106 (-1)
9% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 33
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
73% less capital invested
Capital invested by funds: $125M → $33.5M (-$91.1M)
94% less call options, than puts
Call options by funds: $18K | Put options by funds: $284K
Holders
106
Holders Change
-1
Holders Change %
-0.93%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
12
Increased
30
Reduced
33
Closed
12
Calls
$18K
Puts
$284K
Net Calls
-$266K
Net Calls Change
+$915K
Top Buyers
Top Sellers
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$2.55M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$1.77M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.36M |
| 4 |
Axa
Paris,
France
|
-$1.23M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$524K |
